news_6

Celltrion Submits Investigational New Drug (IND) Application to Initiate a Global Phase III Clinical Trial Evaluating an Inhaled COVID-19 Antibody Cocktail Therapy

Celltrion submitted an IND application for a global Phase III clinical trial of inhaled antibody cocktail therapy with CT-P59 and...

generic_link-5

Economist Impact’s Sustainability Week Asia 2022 highlights the key sustainability trends and goals in the region towards a more equitable and sustainable future

A virtual week discussing how organisations can optimise their ESG performance. HONG KONG SAR - Media OutReach - 7 February 2022 - Online...